Jianyi Capital
Profile, fund size and portfolio
Jianyi Capital is the corporate venture arm of China National Pharmaceutical Group, a pharmaceutical and biotech company. It was founded in 2012 and is based in Shanghai, China. It invests from seed to growth. Sectors it names: medical devices, biotech and life sciences, healthcare and digital health.
- AUM or capital under managementS1
- CNY 6.8bn+
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Seed to Growth |
| Sectors | Medical devices, Biotech and life sciences, Healthcare and digital health |
| Geography | Asia |
| Offices | Shanghai, China |
Sources: S2 Pedaily (Investment Community): Sinopharm Capital renamed Jianyi Capital after ten years; S1 Xinhua Finance: Sinopharm Capital upgraded to Jianyi Capital.
Data behind this graphic
| Measure | Value | Unit | Kind | Source |
|---|---|---|---|---|
| Headline size | CNY 6.8bn+ | AUM or capital under management | Stated by the firm or its parent | S1 |
| Companies backed | 80 | companies | Reported in the press | S2 |
| Companies on the firm's portfolio page | 13 | companies | Counted from the firm's own list | S2 |
Sources: S1 Xinhua Finance: Sinopharm Capital upgraded to Jianyi Capital; S2 Pedaily (Investment Community): Sinopharm Capital renamed Jianyi Capital after ten years.
Where it invests and who leads it
LeadersS2
- Wu AiminFounding Managing PartnerFind on LinkedIn
- Gong YunleiFounding PartnerFind on LinkedIn
- Kuang YongFounding PartnerFind on LinkedIn
- Zou MinPartnerFind on LinkedIn
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | China National Pharmaceutical Group | Single source | S1 |
| Parent industry | Pharmaceuticals and biotech | Single source | S1 |
| Founded | 2012 | Single source | S1 |
| Headquarters | Shanghai, China | Reported by 36Kr PitchHub: Jianyi Capital profile (Shanghai | S4 |
| Status | Active | Single source | S1 |
| Headline size | CNY 6.8bn+ (AUM or capital under management) | Single source | S1 |
| Companies backed | 80 | Single source | S2 |
| Stages | Seed, Series A, Growth (inferred from announced rounds) | Estimate | S2 |
Notable outcomes
IPOs and acquisitions of portfolio companies. Price shown only where published.
Fund vehicles
| Vehicle | Size | Source |
|---|---|---|
| Funds under management since 2012 | CNY 6.5bn | S2 |
Portfolio
Public sources name 13 portfolio companies.S2
The firm also states 80 companies backed. The page list and the stated total measure different things.S2
Every company on the Jianyi Capital list
13 companies, as named in the sources cited.S2 Read the firm's list.
- Artivila Biopharma
- 先通医药
- 凌科药业
- 劲方药业
- 和誉生物
- 国药口腔
- 复诺健生物
- 巨翊科技
- 康立明生物
- 森亿智能 (Synyi AI)
- 爱得科技
- 诚益生物
- 赛分科技
Recent rounds
| Date | Company | Round | Amount | Led by the firm | Source |
|---|---|---|---|---|---|
| 2019-07-03 | 森亿智能 (Synyi AI) | Series C+ | CNY 250M | No | S5 |
History
Sources
- S1Xinhua Finance: Sinopharm Capital upgraded to Jianyi CapitalPress
- S2Pedaily (Investment Community): Sinopharm Capital renamed Jianyi Capital after ten yearsPress
- S3China National Pharmaceutical Investment Co statement: Jianyi Capital is a 35% held associateParent company
- S436Kr PitchHub: Jianyi Capital profile (Shanghai, AUM RMB 6 billion)Third-party report
- S5EqualOcean: Synyi AI raises CNY 250 million Series C, followed by Sinopharm CapitalPress
- S6VCBeat Health: Artivila Biopharma Pre-A+ round led by Jianyi CapitalPress
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Jianyi Capital or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.